Omecamtiv Mecarbil Declines To Improve Exercise Capacity in Patients with HFrEF - MD Magazine

Data show omecamtiv mecarbil added to background therapy had no significant improvement regarding exercise capacity.

New research found that omecamtiv mecarbil did not improve exercise capacity over 20 weeks in well-treated patients with chronic heart failure with reduced ejection fraction (HFrEF). Data show safet… [+2700 chars]

full article...